|
|
Volumn 129, Issue 2, 2007, Pages 129-134
|
|
Antifungal activity and clinical efficacy of liposomal amphotericin B (AmBisome)
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
CYCLOPHOSPHAMIDE;
TOLL LIKE RECEPTOR;
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
ANTIFUNGAL ACTIVITY;
ASPERGILLUS;
CANDIDA;
CRYPTOCOCCUS;
DRUG EFFICACY;
GOLD STANDARD;
IN VITRO STUDY;
IN VIVO STUDY;
MEDICAL RESEARCH;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
REVIEW;
STATISTICAL SIGNIFICANCE;
ANIMAL;
ANTIBIOTIC RESISTANCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
MICROBIOLOGY;
MYCOSIS;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
AMPHOTERICIN B;
ANIMALS;
ANTIBIOTICS, ANTIFUNGAL;
ASPERGILLUS;
CANDIDA;
CLINICAL TRIALS, PHASE II;
CRYPTOCOCCUS;
DRUG RESISTANCE, FUNGAL;
HUMANS;
MYCOSES;
NEUTROPENIA;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 33947716922
PISSN: 00155691
EISSN: 13478397
Source Type: Journal
DOI: 10.1254/fpj.129.129 Document Type: Review |
|
Times cited : (4)
|
|
References (11)
|
